New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 10, 2014
09:06 EDTNUVA, FLDM, CMN, THOR, ELGX, BSX, STJ, DGX, ABCOPiper Jaffray's technical analyst holds an analyst/industry conference call
Technical Analyst Johnson provides a technical review of the firm's Medical Technology covered universe ahead of 4Q results on an Analyst/Industry conference call to be held on January 10 at 10 am.
News For ABCO;BSX;CMN;DGX;ELGX;FLDM;STJ;THOR;NUVA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 19, 2014
07:38 EDTBSXBoston Scientific risk/reward favorable after trial ends, says Wells Fargo
Subscribe for More Information
December 18, 2014
06:18 EDTDGXRedHill Biopharma acquires techonology from University of Minnesota
RedHill Biopharma (RDHL) has entered into a license agreement with the University of Minnesota to acquire the rights to a patented technology to support the development of a commercial diagnostic test for detection of Mycobacterium avium subspecies paratuberculosis bacterium. RedHill's Crohn's disease program RHB-104, currently undergoing a first Phase III study, is based on evidence that Crohn's disease is caused by MAP infection in susceptible patients. As part of development for RHB-104, RedHill is developing, in collaboration with Quest Diagnostics (DGX), a diagnostic test to aid in detecting the presence of MAP in whole blood. RedHill will pay the University of Minnesota a one-time upfront payment and an additional potential milestone payment for the licensed technology. A pre-submission meeting with the FDA to discuss the development path for the diagnostic test is scheduled for January 2015.
December 15, 2014
07:32 EDTNUVAStifel to hold a bus tour
Subscribe for More Information
December 14, 2014
15:56 EDTABCOThe Advisory Board management to meet with JPMorgan
Subscribe for More Information
December 12, 2014
09:02 EDTBSXBoston Scientific presents data of Precision Spinal Cord Stimulator system
Subscribe for More Information
December 11, 2014
10:13 EDTABCOOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:06 EDTABCOThe Advisory Board upgraded at Stifel
As noted earlier, Stifel upgraded The Advisory Board to Buy from Hold. The firm upgraded The Advisory Board after the company acquired Royall, as the firm thinks that a significant amount of growth synergy potential form the deal has not been factored into The Advisory Board's guidance. Stifel expects the company's EBITDA margins to increase, and it is now less concerned that The Advisory Board will miss its mid-teen growth target. Stifel set a $47 price target on the shares.
06:39 EDTABCOThe Advisory Board upgraded to Buy from Hold at Stifel
05:23 EDTSTJSt. Jude Medical announces CE Mark approval of Quadra Allure MP CRT-P
Subscribe for More Information
December 10, 2014
16:11 EDTABCOThe Advisory Board to acquire Royall & Company for $850M
Subscribe for More Information
08:32 EDTCMNCantel Medical reports Q1 non-GAAP EPS 34c, consensus 28c
Subscribe for More Information
07:38 EDTBSXBoston Scientific management to meet with Deutsche Bank
Subscribe for More Information
06:01 EDTBSXBoston Scientific implied volatility of 38 at upper end of index mean range
December 9, 2014
10:27 EDTBSXOptions with increasing implied volatility
Subscribe for More Information
07:44 EDTDGXAmerican Association for Cancer Research to hold a symposium
Subscribe for More Information
December 8, 2014
10:42 EDTBSXOptions with increasing implied volatility
Subscribe for More Information
07:26 EDTFLDMLeerink to hold a tour
Subscribe for More Information
05:53 EDTBSXStocks with implied volatility movement; BSX BMY
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use